Diabetes, Vol 46, Issue 11 1749-1754, Copyright © 1997 by American Diabetes Association

ARTICLES

Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene

WH Herman, SS Fajans, MJ Smith, KS Polonsky, GI Bell and JB Halter
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0354, USA. wherman@umich.edu

Nondiabetic subjects with the Q268X mutation in the hepatocyte nuclear factor (HNF)-4alpha/MODY1 gene have impaired glucose-induced insulin secretion. To ascertain the effects of the nonglucose secretagogue arginine on insulin and glucagon secretion in these subjects, we studied 18 members of the RW pedigree: 7 nondiabetic mutation negative (ND[-]), 7 nondiabetic mutation positive (ND[+]), and 4 diabetic mutation positive (D[+]). We gave arginine as a 5-g bolus, followed by a 25-min infusion at basal glucose concentrations, and after glucose infusion to clamp plasma glucose at approximately 200 mg/dl. The acute insulin response (AIR), the 10-60 min insulin area under the curve (AUC), and the insulin secretion rate (ISR) were compared, as were the acute glucagon response (AGR) and glucagon AUC. The ND[+] and D[+] groups had decreased insulin AUC and ISR and decreased glucose potentiation of AIR, insulin AUC, and ISR to arginine administration when compared with the ND[-] group. At basal glucose concentrations, glucagon AUC was greatest for the ND[-] group, intermediate for the ND[+] group, and lowest for the D[+] group. During the hyperglycemic clamp, there was decreased suppression of glucagon AUC for both ND[+] and D[+] groups compared with the ND[-] group. The decreased ISR to arginine in the ND[+] group compared with the ND[-] group, magnified by glucose potentiation, indicated that HNF-4alpha affects the signaling pathway for arginine-induced insulin secretion. The decrease in glucagon AUC and decreased suppression of glucagon AUC with hyperglycemia suggest that mutations in HNF-4alpha may lead to alpha-cell as well as beta-cell secretory defects or a reduction in pancreatic islet mass.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Ishiyama, M. A. Ravier, and J.-C. Henquin Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E540 - E549. [Abstract] [Full Text] [PDF]

				A. Miura, K. Yamagata, M. Kakei, H. Hatakeyama, N. Takahashi, K. Fukui, T. Nammo, K. Yoneda, Y. Inoue, F. M. Sladek, et al. Hepatocyte Nuclear Factor-4{alpha} Is Essential for Glucose-stimulated Insulin Secretion by Pancreatic beta-Cells J. Biol. Chem., February 24, 2006; 281(8): 5246 - 5257. [Abstract] [Full Text] [PDF]

				Y. H. Hong, U. S. Varanasi, W. Yang, and T. Leff AMP-activated Protein Kinase Regulates HNF4{alpha} Transcriptional Activity by Inhibiting Dimer Formation and Decreasing Protein Stability J. Biol. Chem., July 18, 2003; 278(30): 27495 - 27501. [Abstract] [Full Text] [PDF]

				M. C Gannon, J. A Nuttall, and F. Q Nuttall Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1016 - 1022. [Abstract] [Full Text] [PDF]

				A. Carpentier, B. W. Patterson, N. Leung, and G. F. Lewis Sensitivity to Acute Insulin-Mediated Suppression of Plasma Free Fatty Acids Is Not a Determinant of Fasting VLDL Triglyceride Secretion in Healthy Humans Diabetes, June 1, 2002; 51(6): 1867 - 1875. [Abstract] [Full Text] [PDF]

				P. Vague and L. Nguyen Rationale and Methods for the Estimation of Insulin Secretion in a Given Patient: From Research to Clinical Practice Diabetes, February 1, 2002; 51(90001): S240 - 244. [Abstract] [Full Text] [PDF]

				C. M. Clark Jr., M. H. Chin, S. N. Davis, E. Fisher, R. G. Hiss, D. G. Marrero, E. A. Walker, and J. Wylie-Rosett Incorporating the Results of Diabetes Research Into Clinical Practice: Celebrating 25 years of Diabetes Research and Training Center translation research Diabetes Care, December 1, 2001; 24(12): 2134 - 2142. [Full Text] [PDF]

				S. S. Fajans, G. I. Bell, and K. S. Polonsky Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young N. Engl. J. Med., September 27, 2001; 345(13): 971 - 980. [Full Text] [PDF]

				J. Westerlund and P. Bergsten Glucose Metabolism and Pulsatile Insulin Release From Isolated Islets Diabetes, August 1, 2001; 50(8): 1785 - 1790. [Abstract] [Full Text] [PDF]

				H. Wang, P. Maechler, P. A. Antinozzi, K. A. Hagenfeldt, and C. B. Wollheim Hepatocyte Nuclear Factor 4alpha Regulates the Expression of Pancreatic beta -Cell Genes Implicated in Glucose Metabolism and Nutrient-induced Insulin Secretion J. Biol. Chem., November 10, 2000; 275(46): 35953 - 35959. [Abstract] [Full Text] [PDF]